Habenular molecular targets for depression, impulsivity, and addiction

Snigdha Srivastava; Benjamin R Arenkiel; Ramiro Salas

doi:10.1080/14728222.2023.2257390

Habenular molecular targets for depression, impulsivity, and addiction

Expert Opin Ther Targets. 2023 Jul-Dec;27(9):757-761. doi: 10.1080/14728222.2023.2257390. Epub 2023 Sep 14.

Authors

Snigdha Srivastava^{1

2

3}, Benjamin R Arenkiel^{1

2

3}, Ramiro Salas^{4

5

6

7}

Affiliations

¹ Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
² Jan and Dan Duncan Neurological Institute, Texas Children's Hospital, Houston, TX, USA.
³ Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.
⁴ Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.
⁵ Center for Translational Research on Inflammatory Diseases, Michael E DeBakey VA Medical Center, Houston, TX, USA.
⁶ The Menninger Clinic, Houston, TX, USA.
⁷ Department of Neurosciences, Baylor College of Medicine, Houston, TX, USA.

PMID: 37705488
PMCID: PMC10591939 (available on 2024-09-14)
DOI: 10.1080/14728222.2023.2257390

No abstract available

Keywords: Habenula; NMDA receptor; addiction; cannabinoid receptor 1; depression; impulsivity; ketamine; mu opioid receptor; nicotinic acetylcholine receptor.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Depression* / drug therapy
Humans
Impulsive Behavior
Receptors, Nicotinic*

Substances

Receptors, Nicotinic

Publication types

MeSH terms

Substances

Grants and funding